Cargando…

Sodium restriction in patients with cirrhotic ascites: a protocol for a systematic review

BACKGROUND: Avid renal sodium and water retention among other mechanisms produce ascites in patients with cirrhosis. The main guidelines recommend sodium intake reduction in order to counteract this complication. However, some randomized controlled trials have suggested a lack of benefit with a sodi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walbaum, Benjamin, Valda, María Laura, Rada, Gabriel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862086/ https://www.ncbi.nlm.nih.gov/pubmed/27160239 http://dx.doi.org/10.1186/s13643-016-0250-4

Ejemplares similares

Ayurvedic management of cirrhotic ascites
por: Aswathy, G., et al.
Publicado: (2016)

Surgical Treatment of Cirrhotic Ascites
Publicado: (1927)

Ascitic Fluid Analysis in the Differential Diagnosis of Ascites: Focus on Cirrhotic Ascites
por: Huang, Lin-Lin, et al.
Publicado: (2014)

The Outcome of Cirrhotic Patients with Ascites Is Improved by the Normalization of the Serum Sodium Level by Tolvaptan
por: Kogiso, Tomomi, et al.
Publicado: (2017)

Diagnostic usefulness of the spot urine sodium/potassium ratio in cirrhotic patients with ascites
por: Lee, Jin Wook, et al.
Publicado: (2021)

A Metabolomic Analysis of Cirrhotic Ascites
por: Beyoğlu, Diren, et al.
Publicado: (2022)

Efficacy and safety of umbilical therapy with the traditional Chinese medicine formulation Lishui Xiaogu cataplasm for cirrhotic ascites: protocol for a randomized controlled trial
por: Yang, Xianzhao, et al.
Publicado: (2019)

Comment on ‘Ascitic Fluid Analysis in the Differential Diagnosis of Ascites: Focus on Cirrhotic Ascites’
por: Ahmed, Furqan
Publicado: (2017)

Association of serum sodium and 24-hour urinary sodium level with the severity and complications of ascites in cirrhotic patients
por: Islam, Susmita, et al.
Publicado: (2023)

Undifferentiated shock in a cirrhotic patient: Ascites matters
por: Xenou, Antigoni, et al.
Publicado: (2021)

Use of gloves for the prevention of COVID‐19 in healthy population: A living systematic review protocol
por: Morales, María Belén, et al.
Publicado: (2021)

High mortality of pneumonia in cirrhotic patients with ascites
por: Hung, Tsung-Hsing, et al.
Publicado: (2013)

Management of refractory cirrhotic ascites: challenges and solutions
por: Fukui, Hiroshi, et al.
Publicado: (2018)

Current approaches to the management of patients with cirrhotic ascites
por: Garbuzenko, Dmitry Victorovich, et al.
Publicado: (2019)

Effects and safety of natriuretic peptides as treatment of cirrhotic ascites: A systematic review and meta-analysis
por: Gantzel, Rasmus Hvidbjerg, et al.
Publicado: (2022)

Optimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians
por: Gallo, Andrea, et al.
Publicado: (2020)

Alteration of the serum microbiome composition in cirrhotic patients with ascites
por: Santiago, Alba, et al.
Publicado: (2016)

The Evaluation of Serum Ascites Albumin Gradient and Portal Hypertensive changes in Cirrhotic Patients with Ascites
por: Shahed, Forhad Hossain Md, et al.
Publicado: (2016)

Continuous passive paracentesis versus large-volume paracentesis in the prevention and treatment of intra-abdominal hypertension in the critically ill cirrhotic patient with ascites (COPPTRIAHL): study protocol for a randomized controlled trial
por: Pereira, Rui Antunes, et al.
Publicado: (2023)

Role of Terlipressin in Cirrhotic Patients with Ascites and without Hepatorenal Syndrome: A Systematic Review of Current Evidence
por: Bai, Zhaohui, et al.
Publicado: (2020)

Cardiac dysfunction in cirrhotic portal hypertension with or without ascites
por: Dadhich, Sunil, et al.
Publicado: (2014)

Bacteriologic study of cirrhotic patients with non-neutrocytic ascites
por: Dabiri, Hossein, et al.
Publicado: (2014)

Impact of continued administration of tolvaptan on cirrhotic patients with ascites
por: Kogiso, Tomomi, et al.
Publicado: (2018)

Predictors of Spontaneous Bacterial Peritonitis in Patients with Cirrhotic Ascites
por: Metwally, Khaled, et al.
Publicado: (2018)

Management of Cirrhotic Ascites under the Add-on Administration of Tolvaptan
por: Adachi, Takuya, et al.
Publicado: (2021)

A Telemonitoring Intervention for Cirrhotic Ascites Management Is Cost-Saving
por: Bloom, Patricia P., et al.
Publicado: (2021)

Repetitive and restricted behaviours and anxiety in autism spectrum disorder: protocol for a systematic review and meta-analysis
por: Sellick, Tegan, et al.
Publicado: (2021)

The Role of Serum Procalcitonin Levels in Predicting Ascitic Fluid Infection in Hospitalized Cirrhotic and Non-cirrhotic Patients
por: Cekin, Yesim, et al.
Publicado: (2013)

Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia
por: Wang, Shuzhen, et al.
Publicado: (2018)

Dietary sodium intake and overweight and obesity in children and adults: a protocol for a systematic review and meta-analysis
por: Grimes, Carley A., et al.
Publicado: (2016)

Urea Transporter Inhibitor 25a Reduces Ascites in Cirrhotic Rats
por: Ying, Yi, et al.
Publicado: (2023)

Ascitic Bacterial Composition Is Associated With Clinical Outcomes in Cirrhotic Patients With Culture-Negative and Non-neutrocytic Ascites
por: Chen, Yanfei, et al.
Publicado: (2018)

PROTOCOL: When and how to replicate systematic reviews
por: Karunananthan, Sathya, et al.
Publicado: (2020)

Protocol for sodium depletion and measurement of sodium appetite in mice
por: Park, Seahyung, et al.
Publicado: (2021)

The effectiveness of an educational intervention for sodium restriction in patients with hypertension: study protocol for a randomized controlled trial
por: Rodrigues, Marcela Perdomo, et al.
Publicado: (2017)

The Palliative Management of Refractory Cirrhotic Ascites Using the PleurX(©) Catheter
por: Reinglas, Jason, et al.
Publicado: (2016)

Systemic hemodynamic and renal effects of midodrine and octreotide in cirrhotic patients with ascites
por: Kalambokis, Georgios N., et al.
Publicado: (2011)

Consensus care recommendations for alfapump(®) in cirrhotic patients with refractory or recurrent ascites
por: Aagaard, Niels Kristian, et al.
Publicado: (2022)

Early Administration of Tolvaptan Can Improve Survival in Patients with Cirrhotic Ascites
por: Hosui, Atsushi, et al.
Publicado: (2021)

Serum and ascitic D-dimer in cirrhotic patients with spontaneous bacterial peritonitis
por: El Gohary, Ahmed M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kalco6ijoomg1hf089ck1311rs